Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

New York Valves 2025 - Transcatheter aortic valve intervention (TAVI) with a self-expandable valve with intra-annular leaflet position resulted in positive early outcomes.

Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and recited TAVI with the Navitor valve.

Findings showed that in patients who received intervention with the Navitor valve, a 2% rate of death and stroke at 30 days, excellent hemodynamics and a significant improvement in KCCQ quality of life score were observed.

Interview Questions:
1. Could you tell us about the Navitor valve?
2. What is the study design and patient population?
3. What are the key outcomes?
4. What further research is needed, and what are the next steps?

Recorded remotely from Cincinnati, 2025.

Editors: Yazmin Sadik, Jordan Rance
Videographer: David Ben-Harosh

Support: This is an independent interview produced by Radcliffe Cardiology.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on X:

Чтобы скачать видео "NY Valves 25: Early Outcomes of TAVI Valve with Intra-Annular Leaflet Position" передвинте ползунок вправо